辨证论治原发性支气管肺癌96例
|
摘要
目的辨证论治观察中医药治疗原发性支气管肺癌的疗效。方法将96例肺癌患者分为气虚痰湿组21例,气血瘀滞组28例,气阴两虚组22例,阴虚毒热组25例,通过中医学辨证论治,予以对应的中药治疗,对治疗前及治疗后Karnofsky评分、中医症侯积分及安全性进行观察。结果治疗后Karnofsky评分气虚痰湿组提高率57.14%,稳定率28.57%,总有效率85.71%;气血瘀滞组提高率50%,稳定率35.71%,总有效率85.71%;气阴两虚组提高率50%,稳定率36.36%,总有效率86.36%,阴虚毒热组提高率56%,稳定率28%,总有效率84%;总数提高率53.13%,稳定率32.29%,降低14.58%,总有效率85.42%。中医临床主症、次症积分治疗后与治疗前相比均有明显改善,差异具有统计学意义(P<0.05)。结论辨证治疗原发性支气管肺癌可显著改善患者体力状况及临床症状。
Objective To observe the the clinical curative effect of primary bronchogenic carcinoma based on syndrome differentiation.Methods 96 patients with lung cancer were divided into qi deficiency and phlegm-dampness group of 21 cases, qi-blood stasis group of 28 cases, qi-yin deficiency group of 22 cases, yin deficiency and toxic heat group of 25 cases. Through TCM syndrome differentiation and supply corresponding Chinese medicine treatment, the Karnofsky, Chinese medicine symptoms scores and safety were observed before and after treatment. Results Through the treatment, the Karnofsky increased by 57.14% in the qi deficiency and phlegm dampness group, with a stable rate of 28.57% and a total effective rate of 85.71%. The improvement rate of qi and blood stasis group was 50%, the stability rate was 35.71%, and the total effective rate was 85.71%. The improvement rate was 50%, the stability rate was 36.36%, the total effective rate was 86.36%, the deficiency of yin improvement rate was 56%, the stability rate was28%, and the total effective rate was 84%. The total increase rate was 53.13%, the stability rate was 32.29%, the reduction rate was14.58%, and the total effective rate was 85.42%.2. After the treatment, the main symptoms and secondary symptoms of TCM were significantly improved compared with those before treatment, and the difference was statistically significant( P<0.05). Conclusion The treatment of primary bronchogenic carcinoma can significantly improve the physical condition and clinical symptoms of patients.
Objective To observe the the clinical curative effect of primary bronchogenic carcinoma based on syndrome differentiation.Methods 96 patients with lung cancer were divided into qi deficiency and phlegm-dampness group of 21 cases, qi-blood stasis group of 28 cases, qi-yin deficiency group of 22 cases, yin deficiency and toxic heat group of 25 cases. Through TCM syndrome differentiation and supply corresponding Chinese medicine treatment, the Karnofsky, Chinese medicine symptoms scores and safety were observed before and after treatment. Results Through the treatment, the Karnofsky increased by 57.14% in the qi deficiency and phlegm dampness group, with a stable rate of 28.57% and a total effective rate of 85.71%. The improvement rate of qi and blood stasis group was 50%, the stability rate was 35.71%, and the total effective rate was 85.71%. The improvement rate was 50%, the stability rate was 36.36%, the total effective rate was 86.36%, the deficiency of yin improvement rate was 56%, the stability rate was28%, and the total effective rate was 84%. The total increase rate was 53.13%, the stability rate was 32.29%, the reduction rate was14.58%, and the total effective rate was 85.42%.2. After the treatment, the main symptoms and secondary symptoms of TCM were significantly improved compared with those before treatment, and the difference was statistically significant( P<0.05). Conclusion The treatment of primary bronchogenic carcinoma can significantly improve the physical condition and clinical symptoms of patients.
引文
[1]旋静,连树林.肺癌的中医辨治[J].中国中医药现代远程教育,2015,13(11):7-8.
[2]周岱翰.中医肿瘤学[M].北京:中国中医药出版社,2013:197.
[3]杨付红,张春娣.肺癌的研究现状[J].中国继续医学教育,2015,29(2):30-31.
[4]李金泽.二陈汤加减方联合铂类化疗方案治疗痰证非小细胞肺癌的临床研究[D].北京中医药大学,2016.
[5]郭玉明,姜淼,郑光,等.基于文本挖掘技术分析治疗肺癌的中医用药规律[J].中国实验方剂学杂志,2011,17(16):277-280.
[6]朴钟元.中医药治疗肺癌的研究进展[J].光明中医,2011,26(4):854-855.
[7]雷震霄.中医药治疗肺癌的研究进展[J].湖南中医杂志,2017,33(12):154-156.
[2]周岱翰.中医肿瘤学[M].北京:中国中医药出版社,2013:197.
[3]杨付红,张春娣.肺癌的研究现状[J].中国继续医学教育,2015,29(2):30-31.
[4]李金泽.二陈汤加减方联合铂类化疗方案治疗痰证非小细胞肺癌的临床研究[D].北京中医药大学,2016.
[5]郭玉明,姜淼,郑光,等.基于文本挖掘技术分析治疗肺癌的中医用药规律[J].中国实验方剂学杂志,2011,17(16):277-280.
[6]朴钟元.中医药治疗肺癌的研究进展[J].光明中医,2011,26(4):854-855.
[7]雷震霄.中医药治疗肺癌的研究进展[J].湖南中医杂志,2017,33(12):154-156.